Clearer questions. More informed care.Our commercial disclosure

Costs & billing

Prepaid GLP-1 packages: compare the full commitment

Compare unused-period terms and the entire payment across selected providers, with sources and a disclosed CoreAge Rx placement.

Document research · No independent medical review claimed
On this page
  1. How to use this comparison
  2. 01. CoreAge Rx — commercial first position
  3. 02. Fifty 410
  4. 03. Yucca Health
  5. 04. GobyMeds
  6. 05. Big Easy Weight Loss
  7. 06. Brello Health
  8. Make the comparison specific to you
  9. Sources & research notes

This guide looks at unused-period terms and the entire payment. The aim is to help you ask a better next question, whether you are checking a first prescription offer or thinking about moving to another service.

The services below have different care and payment models. We describe their own published terms and link to fuller files, so an appealing price can be read alongside the work, obligations, and uncertainties attached to it.

How to use this comparison

An attractive average can require a large advance payment. Ask how clinical changes affect remaining care and any financed balance.

CoreAge Rx has a commercial first position in this guide. We may be compensated through its links. The sequence is not an independently calculated medical ranking, and inclusion does not mean every service supplies every feature discussed here.

Use the documents for the actual treatment, location, and payment agreement. A service may be useful to compare even when its approach differs: a consultation-only pathway, an inclusive package, and a care membership should not be assumed to buy the same thing.

  • Name the exact care service.
  • Request the complete payment schedule.
  • Check the product, pharmacy, and exit terms.
Source notes1

01. CoreAge Rx — commercial first position

This is the featured commercial partner. The placement should not be interpreted as proof of superior outcomes, lower total cost, or the best clinical choice for a particular person.

CoreAge Rx describes assessment online followed by dispensing when a clinician issues a prescription. It is Panda Bear’s commercial partner; that arrangement determines its featured position, not an assessment of treatment quality.

Its offer advertises semaglutide from $99 and tirzepatide from $149. The billing help uses $447 paid for three months to illustrate a $149 monthly equivalent. No additional membership fee is advertised, but the selected product and supply period still control the invoice.

Will my receipt show one payment or recurring charges, and which pharmacy will be on the label?

Open our CoreAge Rx review for the terms, evidence limits, and published contact routes.

Source notes23456

02. Fifty 410

Fifty 410 describes provider assessment and follow-up through a portal. Its listed packages include clinical review, medicine, and shipment, but the treatment duration differs between products.

Semaglutide is listed at $199 for a month. Tirzepatide starter treatment is $399 for three months, with other package tiers at $499 and $549. Those figures need to be matched to the actual prescribed package.

Which quoted tier matches the prescription, and what follow-up remains available throughout that package?

Open our Fifty 410 review for the terms, evidence limits, and published contact routes.

Source notes7

03. Yucca Health

Yucca describes online assessment followed by pharmacy preparation where treatment is prescribed. It advertises no extra monthly membership, but readers should still confirm ongoing clinical access.

The current page advertises semaglutide at $125 and tirzepatide at $225 per month on six-month plans. Ask for the full amount collected now, the remaining obligation, and the renewal schedule; the headline does not establish that payments are collected monthly.

How is the six-month plan paid, and what remains owed or refundable if treatment changes?

Open our Yucca Health review for the terms, evidence limits, and published contact routes.

Source notes8

04. GobyMeds

GobyMeds describes starter bundles that include consultation, injection supplies, and delivery. The service says it does not bill insurance and does not add a membership fee.

Three-month starters are listed at $299 for semaglutide and $399 for tirzepatide. The promoted $99 and $133 figures are rounded monthly equivalents, not the full initial payment.

What payment follows the starter bundle, and can I receive the current cancellation policy before purchasing?

Open our GobyMeds review for the terms, evidence limits, and published contact routes.

Source notes9

05. Big Easy Weight Loss

Big Easy Weight Loss publishes packages alongside pharmacy options. Use that information to ask about the intended preparation and dispenser, rather than assuming all quoted options are identical.

The page shows a $399 semaglutide starter offer against $495 regular pricing and $499 tirzepatide against $599. Ask which promotion, pharmacy, and prescribed quantity support the actual quote.

Which pharmacy and supply duration are included in this starter price, and what replaces it on renewal?

Open our Big Easy Weight Loss review for the terms, evidence limits, and published contact routes.

Source notes10

06. Brello Health

Brello combines prescription care with an app and group nutrition or fitness resources. Group sessions are a different service from private appointments with a dietitian or prescriber.

Three-month offers display monthly equivalents of $133 for semaglutide and $166 for tirzepatide. The page describes a three-month minimum and an 11-week renewal interval; confirm the complete checkout amount and next date.

When will the next payment occur, and which individual clinical appointments are included alongside group resources?

Open our Brello Health review for the terms, evidence limits, and published contact routes.

Source notes11

Make the comparison specific to you

After reading the options, select the questions you still need answered. Ask each provider for the same time period, named prescription, and clinical access. Record unclear items as unresolved instead of choosing the lowest advertised number.

If the medicine, route, or treatment goal differs, discuss that difference with the clinician before treating it as an ordinary shopping substitution. The cost worksheet can help compare payments while keeping the medical decision separate.

Source notes12

Trace the information

Sources & research notes

Provider documents describe the provider’s own offer. Official medical references explain context; they do not endorse this publication or its featured partner.

  1. FDA: concerns with unapproved GLP-1 drugs Regulatory / public agency · Checked September 22, 2026
  2. CoreAge Rx: official treatment overview Provider-published information · Checked September 22, 2026
  3. CoreAge Rx: current sale offer Provider-published information · Checked September 22, 2026
  4. CoreAge Rx: plan billing explained Provider-published information · Checked September 22, 2026
  5. CoreAge Rx: contact and professional-entity disclosures Provider-published information · Checked September 22, 2026
  6. CoreAge Rx: purchasing process Provider-published information · Checked September 22, 2026
  7. Fifty 410: official program, pricing, and care details Provider-published information · Checked September 22, 2026
  8. Yucca Health: official program, pricing, and care details Provider-published information · Checked September 22, 2026
  9. GobyMeds: official program, pricing, and care details Provider-published information · Checked September 22, 2026
  10. Big Easy Weight Loss: official program, pricing, and care details Provider-published information · Checked September 22, 2026
  11. Brello Health: official program, pricing, and care details Provider-published information · Checked September 22, 2026
  12. FDA: risks of compounded drugs Regulatory / public agency · Checked September 22, 2026

Use this guide to prepare questions, not to choose or change a prescription without clinical advice. Research method · Commercial disclosure

Your next useful question

Keep the conversation going.